Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase NA 16Phase 3 10Phase 4 3Phase 1/2 3Phase 1 2

Status

Unknown 30Completed 20Recruiting 11Not yet recruiting 10Active not recruiting 5Withdrawn 4Terminated 2

Sponsor Class

INDUSTRY 1202OTHER 899NIH 140NETWORK 21UNKNOWN 3FED 3OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Lymphoma, T-Cell, Peripheral 1

Interventions

parsaclisib 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Terminated × OTHER_GOV × Clear all
NCT05083208 2025-12-02

PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma

Henan Cancer Hospital

Phase 1 Terminated
12 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT00658801 2011-07-08

Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma

National Cancer Center, Korea

Phase 1 Terminated
4 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡